Extranodal NK-T-cell lymphoma epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 9: Line 9:
=== Mortality rate ===
=== Mortality rate ===


* NK cell lymphoma shows a poor prognosis because of rapid local progression and distant metastasis.<ref name="pmid8640683">{{cite journal| author=Harabuchi Y, Imai S, Wakashima J, Hirao M, Kataura A, Osato T et al.| title=Nasal T-cell lymphoma causally associated with Epstein-Barr virus: clinicopathologic, phenotypic, and genotypic studies. | journal=Cancer | year= 1996 | volume= 77 | issue= 10 | pages= 2137-49 | pmid=8640683 | doi=10.1002/(SICI)1097-0142(19960515)77:10<2137::AID-CNCR27>3.0.CO;2-V | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8640683  }}</ref>
* NK cell lymphoma shows a poor prognosis because of rapid local progression and distant metastasis.


=== Race ===
=== Race ===


* Natural Killer (NK) cell lymphoma is a rare disease. NK/T cell lymphoma, nasal type (NKTCL) and aggressive NK-cell leukemia (ANKCL) have a higher incidence in Asia, Central, and South America.<ref name="pmid86406832">{{cite journal| author=Harabuchi Y, Imai S, Wakashima J, Hirao M, Kataura A, Osato T et al.| title=Nasal T-cell lymphoma causally associated with Epstein-Barr virus: clinicopathologic, phenotypic, and genotypic studies. | journal=Cancer | year= 1996 | volume= 77 | issue= 10 | pages= 2137-49 | pmid=8640683 | doi=10.1002/(SICI)1097-0142(19960515)77:10<2137::AID-CNCR27>3.0.CO;2-V | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8640683  }}</ref>
* Natural Killer (NK) cell lymphoma is a rare disease. NK/T cell lymphoma, nasal type (NKTCL) and aggressive NK-cell leukemia (ANKCL) have a higher incidence in Asia, Central, and South America.
* Nk cell lymphoma is usually associated with Epstein-Barr virus infection.
* Nk cell lymphoma is usually associated with Epstein-Barr virus infection.


=== Gender ===
=== Gender ===


* Extranodal NK/T-cell lymphoma shows male preponderance.<ref name="pmid27932776">{{cite journal| author=Al Shawabkeh MA, Al Sulaiti M, Al Sa'ey H, Ganesan S| title=Nasal Type Extranodal Natural Killer/T (NK/T) Cell Lymphoma Presenting as Periorbital Cellulitis: A Case Report. | journal=Am J Case Rep | year= 2016 | volume= 17 | issue=  | pages= 934-938 | pmid=27932776 | doi=10.12659/ajcr.899922 | pmc=5153321 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27932776  }}</ref>
* Extranodal NK/T-cell lymphoma shows male preponderance.


=== Region ===
=== Region ===


*NK T cell lymphoma, nasal type (NNKTL) consist 3-10% of non-Hodgkin lymphoma in Asia and South America and less than 1% in Western countries.
*NK T cell lymphoma, nasal type (NNKTL) consist 3-10% of non-Hodgkin lymphoma in Asia and South America and less than 1% in Western countries.<ref name="AozasaTakakuwa2008">{{cite journal|last1=Aozasa|first1=Katsuyuki|last2=Takakuwa|first2=Tetsuya|last3=Hongyo|first3=Tadashi|last4=Yang|first4=Woo-Ick|title=Nasal NK/T-cell lymphoma: epidemiology and pathogenesis|journal=International Journal of Hematology|volume=87|issue=2|year=2008|pages=110–117|issn=0925-5710|doi=10.1007/s12185-008-0021-7}}</ref>
*It is estimated the incidence of NNKTL is higher in Asia by 10-folds.
*It is estimated the incidence of NNKTL is higher in Asia by 10-folds.


=== Age ===
=== Age ===


* The median age of onset is approximately 50 years and it is common in elderly.
* The median age of onset is approximately 50 years and it is common in elderly.<ref name="AozasaTakakuwa20082">{{cite journal|last1=Aozasa|first1=Katsuyuki|last2=Takakuwa|first2=Tetsuya|last3=Hongyo|first3=Tadashi|last4=Yang|first4=Woo-Ick|title=Nasal NK/T-cell lymphoma: epidemiology and pathogenesis|journal=International Journal of Hematology|volume=87|issue=2|year=2008|pages=110–117|issn=0925-5710|doi=10.1007/s12185-008-0021-7}}</ref>
* Extranodal NK/T-cell lymphoma is a rare disease in children and often it is associated with mosquito-bite hypersensetivity or other EBV-associated disease.<ref name="pmid23341729">{{cite journal| author=Seon HS, Roh JH, Lee SH, Kang EK| title=A case of hypersensitivity to mosquito bites without peripheral natural killer cell lymphocytosis in a 6-year-old Korean boy. | journal=J Korean Med Sci | year= 2013 | volume= 28 | issue= 1 | pages= 164-6 | pmid=23341729 | doi=10.3346/jkms.2013.28.1.164 | pmc=3546098 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23341729  }}</ref>
* Extranodal NK/T-cell lymphoma is a rare disease in children and often it is associated with mosquito-bite hypersensetivity or other EBV-associated disease.


*
*

Revision as of 14:18, 22 August 2019

Extranodal NK-T-cell lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Extranodal NK-T-cell lymphoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Xray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Extranodal NK-T-cell lymphoma epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Extranodal NK-T-cell lymphoma epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Extranodal NK-T-cell lymphoma epidemiology and demographics

CDC on Extranodal NK-T-cell lymphoma epidemiology and demographics

Extranodal NK-T-cell lymphoma epidemiology and demographics in the news

Blogs on Extranodal NK-T-cell lymphoma epidemiology and demographics

Risk calculators and risk factors for Extranodal NK-T-cell lymphoma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2] Sowminya Arikapudi, M.B,B.S. [3]

Overview


Epidemiology and Demographics

Mortality rate

  • NK cell lymphoma shows a poor prognosis because of rapid local progression and distant metastasis.

Race

  • Natural Killer (NK) cell lymphoma is a rare disease. NK/T cell lymphoma, nasal type (NKTCL) and aggressive NK-cell leukemia (ANKCL) have a higher incidence in Asia, Central, and South America.
  • Nk cell lymphoma is usually associated with Epstein-Barr virus infection.

Gender

  • Extranodal NK/T-cell lymphoma shows male preponderance.

Region

  • NK T cell lymphoma, nasal type (NNKTL) consist 3-10% of non-Hodgkin lymphoma in Asia and South America and less than 1% in Western countries.[1]
  • It is estimated the incidence of NNKTL is higher in Asia by 10-folds.

Age

  • The median age of onset is approximately 50 years and it is common in elderly.[2]
  • Extranodal NK/T-cell lymphoma is a rare disease in children and often it is associated with mosquito-bite hypersensetivity or other EBV-associated disease.

References

  1. Aozasa, Katsuyuki; Takakuwa, Tetsuya; Hongyo, Tadashi; Yang, Woo-Ick (2008). "Nasal NK/T-cell lymphoma: epidemiology and pathogenesis". International Journal of Hematology. 87 (2): 110–117. doi:10.1007/s12185-008-0021-7. ISSN 0925-5710.
  2. Aozasa, Katsuyuki; Takakuwa, Tetsuya; Hongyo, Tadashi; Yang, Woo-Ick (2008). "Nasal NK/T-cell lymphoma: epidemiology and pathogenesis". International Journal of Hematology. 87 (2): 110–117. doi:10.1007/s12185-008-0021-7. ISSN 0925-5710.